Skip to main content
. Author manuscript; available in PMC: 2014 May 1.
Published in final edited form as: ChemMedChem. 2013 Mar 18;8(5):847–857. doi: 10.1002/cmdc.201300007

Table 1.

Antiprion potency for AMT analogs.

graphic file with name nihms523172u1.jpg
Cmpd R = X = EC50 ± SEM(nM)[a] n[B]
1 Phenyl CH3 1290 ± 122 85
12 pyridin-4-yl CH3 87 ± 43 3
13 pyridin-4-yl N-oxide CH3 559 ± 120 3
14 2-Me-pyridin-4-yl CH3 400 ± 61 3
15 pyridin-3-yl CH3 68 ± 13 5
16 pyridin-3-yl N-oxide CH3 203 ± 10 3
17 2-Me-pyridin-3-yl CH3 618 ± 54 3
18 graphic file with name nihms523172t1.jpg CH3 89 ± 35 3
19 graphic file with name nihms523172t2.jpg CH3 2133 ± 226 3
20 N-Me-piperazinyl CH3 840 ± 132 3
21 morpholino CH3 51 ± 7 3
22 phenyl MeOCH2CH2O- >10,000 3
23 phenyl Me2N- 699 ± 87 3
24 phenyl N-Me-piperazinyl 1183 ± 206 5
[a]

antiprion potency in ScN2a-cl3 cells by ELISA; SEM is calculated as standard deviation divided by the square root of n.

[b]

number of repetitions.